Literature DB >> 23348761

Development of a standardized MRI scoring tool for CNS demyelination in children.

L H Verhey1, H M Branson, S Laughlin, M M Shroff, S M Benseler, B M Feldman, D L Streiner, J G Sled, B Banwell.   

Abstract

BACKGROUND AND
PURPOSE: The degree to which MR imaging is useful in the diagnosis of MS is predicated on standardized and reliable evaluation of MR imaging parameters. We aimed to devise items for an MR imaging scoring tool that would have high inter-rater agreement and would be straightforward to apply.
MATERIALS AND METHODS: On the basis of a literature search and consensus of an expert panel, we identified 48 parameters that describe acute CNS demyelination, predict MS diagnosis, or characterize demyelinating disorder mimics. MR images of children with clinically confirmed MS, monophasic ADEM, and angiography-negative biopsy-positive small-vessel primary angiitis of the CNS were scored by 2 neuroradiologists independently, using the preliminary 48-parameter tool. Parameters with Cohen κ ≥ 0.6 and deemed important in predicting diagnosis were retained. Parameters not visualized on routine clinical imaging or not important in differentiating MS, ADEM, and SV-cPACNS were discarded.
RESULTS: Of 65 eligible patients, 55 children were enrolled (16 with monophasic ADEM, 27 with MS, 12 with SV-cPACNS); 10 were excluded (6 had hard-copy films, 4 did not meet MR imaging quality requirements). Of the 48 parameters, 16 were retained in the final scoring tool. The remaining 28 parameters were discarded: 4 had κ < 0.6 and were not deemed useful in predicting diagnosis; 9 were not visible on routinely acquired clinical images; and 15 had inter-rater agreement ≥0.6 but were not useful in differentiating monophasic ADEM, MS, and SV-cPACNS.
CONCLUSIONS: We propose a 16-parameter MR imaging scoring tool that is straightforward to apply in the clinical setting and demonstrates high inter-rater agreement.

Entities:  

Mesh:

Year:  2013        PMID: 23348761      PMCID: PMC7964584          DOI: 10.3174/ajnr.A3382

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  31 in total

1.  Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.

Authors:  H S Malhotra; K K Jain; A Agarwal; M K Singh; S K Yadav; M Husain; N Krishnani; R K Gupta
Journal:  Mult Scler       Date:  2009-02       Impact factor: 6.312

2.  Enterovirus 71-related encephalomyelitis: usual and unusual magnetic resonance imaging findings.

Authors:  Seonah Jang; Sang-il Suh; Su Min Ha; Jung Hye Byeon; Baik-Lin Eun; Young Hen Lee; Hyung Suk Seo; So-Hee Eun; Hae-Young Seol
Journal:  Neuroradiology       Date:  2011-08-24       Impact factor: 2.804

3.  MR imaging of leptomeningeal metastases: comparison of three sequences.

Authors:  Sanjay K Singh; Norman E Leeds; Lawrence E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

5.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

6.  The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms.

Authors:  Judy Pang; Anuradha Banerjee; Tarik Tihan
Journal:  J Neurooncol       Date:  2007-11-07       Impact factor: 4.130

7.  The interobserver reliability of the revised American Spinal Injury Association standards for neurological classification of spinal injury patients.

Authors:  M M Priebe; W P Waring
Journal:  Am J Phys Med Rehabil       Date:  1991-10       Impact factor: 2.159

8.  Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging.

Authors:  S Warach; J Gaa; B Siewert; P Wielopolski; R R Edelman
Journal:  Ann Neurol       Date:  1995-02       Impact factor: 10.422

Review 9.  MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

Authors:  Arnaud Charil; Tarek A Yousry; Marco Rovaris; Frederik Barkhof; Nicola De Stefano; Franz Fazekas; David H Miller; Xavier Montalban; Jack H Simon; Chris Polman; Massimo Filippi
Journal:  Lancet Neurol       Date:  2006-10       Impact factor: 44.182

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  5 in total

1.  MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein.

Authors:  Matthias Baumann; Astrid Grams; Tanja Djurdjevic; Eva-Maria Wendel; Christian Lechner; Bettina Behring; Astrid Blaschek; Katharina Diepold; Astrid Eisenkölbl; Joel Fluss; Michael Karenfort; Johannes Koch; Bahadir Konuşkan; Steffen Leiz; Andreas Merkenschlager; Daniela Pohl; Mareike Schimmel; Charlotte Thiels; Barbara Kornek; Kathrin Schanda; Markus Reindl; Kevin Rostásy
Journal:  J Neurol       Date:  2018-02-08       Impact factor: 4.849

Review 2.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

3.  Precision Medicine: The new era in medicine.

Authors:  Marinka Twilt
Journal:  EBioMedicine       Date:  2016-02-08       Impact factor: 8.143

4.  Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies.

Authors:  Andreas Wegener-Panzer; Robert Cleaveland; Eva-Maria Wendel; Matthias Baumann; Annikki Bertolini; Martin Häusler; Ellen Knierim; Edith Reiter-Fink; Markus Breu; Özcan Sönmez; Adela Della Marina; Renate Peters; Christian Lechner; Martin Piepkorn; Claudia Roll; Romana Höftberger; Frank Leypoldt; Markus Reindl; Kevin Rostásy
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-05-01

Review 5.  Primary angiitis of the central nervous system: diagnosis and treatment.

Authors:  Carolin Beuker; Antje Schmidt; Daniel Strunk; Peter B Sporns; Heinz Wiendl; Sven G Meuth; Jens Minnerup
Journal:  Ther Adv Neurol Disord       Date:  2018-07-09       Impact factor: 6.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.